Back to Browse Journals » Open Access Surgery » Volume 1

Gamma knife radiosurgery for uveal melanoma ineligible for brachytherapy by the Collaborative Ocular Melanoma Study criteria

Authors Nicola G Ghazi, Christopher S Ketcherside, Jason Sheehan, Brian P Conway

Published Date September 2008 Volume 2008:1 Pages 21—24

DOI http://dx.doi.org/10.2147/OAS.S3654

Published 30 September 2008

Nicola G Ghazi1, Christopher S Ketcherside1, Jason Sheehan2, Brian P Conway1

1Department of Ophthalmology and 2Neurosurgery, University of Virginia Health System, Charlottesville, VA, USA

Purpose: To report outcomes of Gamma Knife radiosurgery (GKRS) in treating uveal melanoma lesions ineligible for standard brachytherapy.

Methods: A retrospective interventional case series of uveal melanoma patients treated with GKRS between 1996 and 2004 was performed. The main outcome measures were local tumor control, metastasis, and death.

Results: Four patients with uveal melanoma treated with GKS were identified. Three tumors involved the ciliary body and one was macular with its border within 2 mm of the optic disc. Adequate globe stabilization was achieved by retrobulbar anesthesia in all cases. Pretreatment mean visual acuity was 20/30. Tumor volume as determined by magnetic resonance imaging ranged from 0.05 to 0.30 cc. Ultrasonographic greatest tumor diameter and height ranged from 11 to 18 mm (mean 14.5 mm) and 2.9 to 4.5 mm (mean 3.6 mm), respectively. The peripheral dose varied from 16.5 to 30 Gray. Local tumor control was achieved in all cases over a follow up period of 6 to 96 months. Mean final visual acuity was 20/50. One eye was enucleated for neovascular glaucoma and one patient died from liver and lung metastasis.

Conclusions: GKRS for uveal melanoma appears to be safe and effective. The metastasis and mortality rates appear to be comparable to those following brachytherapy and enucleation. Moreover, local tumor control and enucleation rates are similar to those following brachytherapy. The findings in this small series suggest a role for GKRS in the treatment of selected cases of uveal melanomas.

Keywords: gamma knife radiosurgery, radiation therapy, uveal melanoma

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other article by this author:

Is reduction in the risk of vision loss the only benefit of photodynamic therapy in predominantly classic subfoveal choroidal neovascularization?

Nicola G Ghazi, Brian P Conway, James S Tiedeman, Steven J Yoon

Clinical Ophthalmology 2008, 2:773-780

Published Date: 18 September 2008

Readers of this article also read:

Evaluation of 188Re-labeled PEGylated nanoliposome as a radionuclide therapeutic agent in an orthotopic glioma-bearing rat model

Huang FYJ, Lee TW, Chang CH, Chen LC, Hsu WH, Chang CW, Lo JM

International Journal of Nanomedicine 2015, 10:463-473

Published Date: 9 January 2015

Fibrin glue for Gundersen flap surgery

Chung HW, Mehta JS

Clinical Ophthalmology 2013, 7:479-484

Published Date: 6 March 2013

Efficacy of the anti-VZV (anti-HSV3) vaccine in HSV1 and HSV2 recurrent herpes simplex disease: a prospective study

Le Goaster J, Gonzalo S, Bouree P, Tangy F, Haenni AL

Open Access Journal of Clinical Trials 2012, 4:51-58

Published Date: 30 July 2012

Coronary sinus intervention for the treatment of refractory angina pectoris

Yoav Paz, Amihay Shinfeld

Vascular Health and Risk Management 2011, 7:135-136

Published Date: 3 March 2011

Corneal abrasion

Scott Fraser

Clinical Ophthalmology 2010, 4:387-390

Published Date: 26 April 2010

Fibrinogen as a risk factor for premature myocardial infarction in Iranian patients: A case control study

Mohammad Shojaie, Morteza Pourahmad, Ahad Eshraghian, et al

Vascular Health and Risk Management 2009, 5:673-676

Published Date: 11 August 2009

Immediate and six months clinical and angiographic results of intracoronary paclitaxel-coated stent implantation – the Meo:DrugStar-1 study

Cihangir Uyan, Huseyin Arinc, Huseyin Gunduz, Ramazan Akdemir

Vascular Health and Risk Management 2008, 4:173-176

Published Date: 6 March 2008